Akagera Medicines gets Rwf11.5bn grant to advance TB vaccine trials

Akagera Medicines, is a biotechnology company majority-owned by Rwandans.
Akagera Medicines, is a biotechnology company majority-owned by Rwandans.
Alice Umutesi